
Alzheimers Drugs Market, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Therapy, Pipeline Drugs), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Onli
Description
Alzheimer's disease is a progressive neurodegenerative disease that slowly destroys memory and cognitive skills. It is the most common cause of dementia among older people. Global Alzheimer's drugs market growth is driven by rising prevalence of Alzheimer's disease worldwide. According to WHO, around 50 million people globally have dementia with nearly 10 million new cases every year. Rising approval and launch of novel disease modifying drugs that target the underlying pathophysiology of Alzheimer's can drive the market growth over the forecast period.
Market Dynamics:
Global Alzheimer's drugs market growth is driven by rising geriatric population, increasing prevalence of Alzheimer's disease, introduction of novel disease modifying drugs, growing healthcare expenditure and rising awareness about the condition. However, high costs associated with drug R&D and failure of late stage clinical trials can hamper the market growth. Developing regions with large elderly populations an offer significant growth opportunities. Technological advancements in early diagnosis and advancements in understanding the disease pathology can also offer new opportunities.
Key Features of the Study:
Market Dynamics:
Global Alzheimer's drugs market growth is driven by rising geriatric population, increasing prevalence of Alzheimer's disease, introduction of novel disease modifying drugs, growing healthcare expenditure and rising awareness about the condition. However, high costs associated with drug R&D and failure of late stage clinical trials can hamper the market growth. Developing regions with large elderly populations an offer significant growth opportunities. Technological advancements in early diagnosis and advancements in understanding the disease pathology can also offer new opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global Alzheimer's drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Alzheimer's drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie, Inc., Teva Pharmaceuticals Ltd., Eisai Co., Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Novartis AG, Zydus Lifesciences Ltd (CADILA), Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Amneal Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Viatris Inc., Lupin Ltd, Cipla Ltd., Torrent Pharmaceuticals Ltd., Unichem laboratories ltd, Lannett Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Alzheimer's drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Alzheimer's drugs market
- By Drug Class
- Cholinesterase Inhibitors
- Donepezil
- Rivastigmine
- Galantamine
- NMDA Receptor Antagonist
- Memantine
- Combination Therapy
- Donepezil and Memantine
- Pipeline Drugs
- Aducanumab
- Lecanemab
- Donanemab
- By Route of Administration
- Oral
- Parenteral
- Others
- By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AbbVie, Inc.
- Teva Pharmaceuticals Ltd.
- Eisai Co., Ltd.
- Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
- Novartis AG
- Zydus Lifesciences Ltd (CADILA)
- Sun Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd
- Aurobindo Pharma Ltd
- Amneal Pharmaceuticals Inc.
- Macleods Pharmaceuticals Ltd.
- Viatris Inc.
- Lupin Ltd
- Cipla Ltd.
- Torrent Pharmaceuticals Ltd.
- Unichem laboratories ltd
- Lannett Inc.
Table of Contents
180 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
- 4. Global Alzheimer’s Drugs Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
- 5. Global Alzheimer’s Drugs Market, By Drug Class, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segment Trends
- Cholinesterase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Donepezil
- Rivastigmine
- Galantamine
- NMDA Receptor Antagonist
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Memantine
- Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Donepezil and Memantine
- Pipeline Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Aducanumab
- Lecanemab
- Donanemab
- 6. Global Alzheimer’s Drugs Market, By Route of Administration, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 7. Global Alzheimer’s Drugs Market, By Distribution Channel, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 8. Global Alzheimer’s Drugs Market, By Region, 2020 – 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Company Profiles
- AbbVie, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
- Novartis AG
- Zydus Lifesciences Ltd (CADILA)
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd
- Aurobindo Pharma Ltd
- Amneal Pharmaceuticals Inc.
- Macleods Pharmaceuticals Ltd.
- Viatris Inc.
- Lupin Ltd
- Cipla Ltd.
- Torrent Pharmaceuticals Ltd.
- Unichem laboratories ltd
- Lannett Inc.
- 10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.